Study of Mifepristone and Misoprostol Vs Misoprostol alone in mid trimester termination of pregnancy in tertiary care hospital
Abstract
Background: Over the last decade there is an increase in number of second trimester pregnancy termination due to better prenatal screening. Medical methods, using combination of Mifepristone Misoprostol are increasing being used for mid-trimester pregnancy termination.
Objective: The present study was conducted with an aim toassess and comparatively evaluate the efficacy of Mifepristone with Misoprostol and Misoprostol alone for mid trimester termination of pregnancy.
Methods and Material: A prospective study was conducted on 50 women who presented to us for termination of pregnancy in the mid trimester due to various reasons. These 50 women were divided into two groups of 25 each. In the study group 1, Mifepristone 200mg was given 24hours before intravaginalinsertion of 200mcg of Misoprostol followed by 200mcg every 6hrs until abortion occurs.In the control group 2, only Misoprostol was inserted in the same dose regime. The results were analysed for Primary outcomes i.e. Rate of complete abortion, Induction to abortion interval and failure to achieve complete abortion.
Result: Mean induction abortion interval from insertion of the first Misoprostol tablet was significantly shorter in the Mifepristone pre-treated [mean duration7hours] group as compared to Misoprostol alone group [mean duration 18hours]. The mean dose of misoprostol required was significantly less in the study group[around 400mcg] and complete abortion occurred in 100% of casesas compared to control group in whom the mean dose of Misoprostol required was more [around1200mcg], with 8% failure for which Hysterotomy was done.
Conclusion: Pre-treatment with Mifepristone 24hr before intravaginal Misoprostol significantly improves induction abortion interval.
Downloads
References
2. Drey EA, Foster DG, Jackson RA, et al. Risk factors associated with presenting for abortion in the second trimester. DOI:10.1097/01.AOG. 0000189095. 32382.d0
3. Grimes DA. The continuing need for late abortions. JAMA. 1998 Aug 26;280(8):747-50.
4. Medical methods for termination of pregnancy. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser. 1997;871:i-vii, 1-110.
5. Lalitkumar S, Bygdeman M, Gemzell-Danielsson K. Mid-trimester induced abortion: a review. DOI:10.1093/ humupd/dml049
6. Hammond C. Recent advances in second-trimester abortion: an evidence-based review. DOI:10.1016/j.ajog. 2008.11.016
7. Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception. 2004 Jan;69 (1): 51-8.
8. Bygdeman M, Swahn ML. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy. Contraception. 1985 Jul;32(1):45-51.
9. Nagaria T, Sirmor N. Misoprostol vs mifepristone and misoprostol in second trimester termination of pregnancy. DOI:10.1007/s13224-011-0118-4
10. Hamoda H, Ashok PW, Flett GM, Templeton A. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation. DOI:10.1093/ humrep/ dei037
11. Ho PC, Ngai SW, Liu KL, et al. Vaginal misoprostol compared with oral misoprostol in termination of second-trimesterpregnancy.DOI:10.1016/S0029-7844(97)00419-5
12. Ngai SW, Tang OS and Ho PC. Randomised comparison of vaginal (200 mcg every 3 hourly) and oral (400 mcg every 3 hourly) Misoprostol when combined with mifepristone in termination of second trimester pregnancy. Hum Rep 200;15:2205-8.
13. Tang OS, Chan CC, Kan AS, Ho PC. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation. DOI:10. 1093/humrep/dei196
14. el-Refaey H, Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens.Hum Reprod.1995 Feb;10(2):475-8.
15. Agarwal N, Gandhi G, Batra S, Sharma R. Evaluation of mifepristone and Misoprostol for medical termination of pregnancy between 13-20 weeks of gestation. Indian Journal of Clinical practice. 2014;24(9):859-62.
16. Chen M, Shih Jc, Chiu WT, Hsieh FJ. Separation of caesarean scar during second trimester intravaginal Misoprostol abortion. ObstetGynaecol1999;94:840.
17. Berghahn L, Christensen D, Droste S. Uterine rupture during second-trimester abortion associated with misoprostol. Obstet Gynecol. 2001 Nov; 98(5 Pt 2):976-7.
18. Dickinson JE. Misoprostol for second-trimester pregnancy termination in women with a prior caesarean delivery. DOI:10.1097/01.AOG.0000151996.16422.88
19. Herabutya Y, Chanarachakul B, Punyavachira P. Induction of labor with vaginal misoprostol for second trimester termination of pregnancy in the scarred uterus. Int J Gynaecol Obstet. 2003 Dec;83(3):293-7.
Copyright (c) 2018 Author (s). Published by Siddharth Health Research and Social Welfare Society
This work is licensed under a Creative Commons Attribution 4.0 International License.
OAI - Open Archives Initiative
Therapoid
